the corporate venture capital fund of everis group

about us

FiTalent is the corporate venture capital fund of everis group.

It is the bet on entrepreneurship and young talent carried out by everis group, being our mission to support entrepreneurs to transform their ventures into profitable, leading companies.

everis is an NTT DATA Company

dedicated to consulting and outsourcing in all sectors, with a turnover of 1.03 billion Euro in the last financial year. We are a large family with 19,000 professionals across Europe, USA and Latin Americas.

strategy

FIT-II (everis’ corporate venture capital fund) looks for investment opportunities relying on committed teams and innovative technology. In this new investment phase, FIT-II has reinforced its commitment with innovation through the development of three different strategic lines, each of them with its own portfolio:

our portfolio

  • CIRCULAR (FIT-II)

    Circular is a private community in which startups refer candidates they interviewed, but who weren’t the exact right fit. Circular will match these qualified people with other startups in the community which are looking for great talent.

  • BOX MOTIONS (FIT-II)

    Box Motions introduces a new concept of storage (“we collect your stuff for free, we store it and bring it to you at anytime”).

  • INLAB (FIT-II)

    The main activity of Internet Laboratory Digital, S.L is the development and commercialization of an advertising platform for companies called "InLab Digital", which consists of buying advertising spaces in the digital environment.

  • BOOBOO (FIT-II)

    Booboo is a collective optimization network of the logistics and transport sector.

  • Ability pharma

    is a biopharmaceutical company focused on creating the future of oncology by developing innovative therapies that address unmet medical needs

  • Medibiofarma

    is a biopharmaceutical focused on development of novel drugs for the treatment of cancer, specifically through the activation of immune system.

newsroom

  • Medibiofarma
    FiTalent (FIT-II) invests in Medibiofarma, a Spanish biotechnology company founded in 2016 by a grou...
    read more
  • Ability Pharma
    FiTalent (FIT-II) invests in Ability Pharma, a clinical-stage biopharmaceutical company focused on d...
    read more
  • Ici Red
    IciRed is the first online platform of commercial incidents due to default that attacks online reput...
    read more

members of

members-of-ascri
members-of-esade
members-of-iese
members-of-keiretsu-forum
members-of-asebio

Contact Us

We want to know about your project, get in touch with us

Contact